Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neurology|July 1, 1988
Clinical experience with COP-1 in multiple sclerosisM B Bornstein, A Miller, S Slagle, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 11, 1999
Relationship between lipoprotein- and oxidation-related variables and atheroma lipid composition in subjects undergoing coronary artery bypass graft surgeryW Y Craig, M W Rawstron, C A Rundell, et al.
Atherosclerosis|June 28, 2001
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemiaW Insull, M Koren, J Davignon, et al.
Annals of Surgical Oncology|June 27, 2023
NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic CholangiocarcinomaShishir K Maithel, Jessica M Keilson, Hop S Tran Cao, et al.
JAMA|January 10, 1996
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemiaR G Bakker-Arkema, M H Davidson, R J Goldstein, et al.
Annals of Surgical Oncology|October 21, 2022
Is There a Role for Adjuvant Chemotherapy in Pathologic Node-Negative Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy?Jessica M Keilson, Adriana C Gamboa, Michael K Turgeon, et al.
Vascular Medicine (London, England)|August 28, 2020
Skeletal muscle expression of adipose-specific phospholipase in peripheral artery diseaseCaitlin Parmer, Ana Luisa De Sousa-Coelho, Henry S Cheng, et al.
Journal of Surgical Oncology|July 16, 2021
Radiological assessment of persistent retroperitoneal and lateral pelvic lymph nodes after neoadjuvant therapy for rectal cancer: An analysis of the United States Rectal Cancer ConsortiumMichael K Turgeon, Adriana C Gamboa, Jessica M Keilson, et al.
Journal of Surgical Oncology|June 1, 2021
Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?Michael K Turgeon, Rachel M Lee, Jessica M Keilson, et al.
Clinical Cardiology|January 24, 2003
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemiaJonathan Isaacsohn, Donald Hunninghake, Helmut Schrott, et al.
Pageof 3